These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 4217702)
1. [Proceedings: Clinical significance of oral TRH test in various endocrine diseases]. Hirooka Y; Wanibe H; Yamauchi K; Mitsuma T; Nagasaka A Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):106. PubMed ID: 4217702 [No Abstract] [Full Text] [Related]
2. [Proceedings: Use of the peroral TRH-T4 test in endocrinologic diagnosis]. König MP; Riek M; Studer H Helv Med Acta; 1974 May; 37(5-6):364. PubMed ID: 4212779 [No Abstract] [Full Text] [Related]
3. [Proceedings: TRH test. Results and clinical application]. Dutau G; Rochiccioli P Arch Fr Pediatr; 1975; 32(6):591. PubMed ID: 810112 [No Abstract] [Full Text] [Related]
4. Administration of synthetic thyrotropin releasing hormone (TRH) as a clinical test for pituitary thyrotropin reserve. Gual C; Wilber JF; Tello C; Ríos E Rev Invest Clin; 1972; 24(1):35-55. PubMed ID: 4624320 [No Abstract] [Full Text] [Related]
5. [TRH test I. A review of the clinical diagnostic use of the thyrotropin releasing hormone]. Dige-Petersen H; Hummer L Ugeskr Laeger; 1974 Jun; 136(25):1351-5. PubMed ID: 4210163 [No Abstract] [Full Text] [Related]
7. Oral administration of thyrotropin-releasing hormone (TRH) in the diagnosis of thyreopathies. Felt V; Nedvídková J Czech Med; 1978; 1(3):162-8. PubMed ID: 100297 [TBL] [Abstract][Full Text] [Related]
8. [Advantages of the oral TRH test for the diagnosis of thyroid gland diseases]. Staub JJ Dtsch Med Wochenschr; 1979 Jul; 104(28):1019. PubMed ID: 110576 [No Abstract] [Full Text] [Related]
9. [Thyrotropin releasing factor (TRF) test: standardization of pituitary TSH secretion potential test and results in various endocrine diseases]. Otsuki M; Mori S; Kusaka T; Tateiwa M; Sakota M Horumon To Rinsho; 1973 Mar; 21(3):307-16. PubMed ID: 4200111 [No Abstract] [Full Text] [Related]
10. [TRH induced TSH release in 33 patients with hyperprolactinemia]. Völker W; von zur Mühlen A Arch Gynecol; 1979 Jul; 228(1-4):584. PubMed ID: 114124 [No Abstract] [Full Text] [Related]
11. [An oral test using thyrotropin releasing hormone in the diagnosis of the thyroid diseases]. Felt V; Nedvídková J Cas Lek Cesk; 1977 Jun; 116(24):740-2. PubMed ID: 407001 [No Abstract] [Full Text] [Related]
12. [Indications for oral TRH in a study of 998 patients (author's transl)]. Rinck PA; Botsch H; Rossdeutscher R Rofo; 1981 Feb; 134(2):198-200. PubMed ID: 6452363 [TBL] [Abstract][Full Text] [Related]
13. [Response of the thyrotropic hormone after oral administration of thyrotropin releasing hormone in patients with disorders of the thyroid gland]. Nedvídková J; Felt V Vnitr Lek; 1976 Mar; 22(3):278-82. PubMed ID: 817509 [No Abstract] [Full Text] [Related]
14. [Oral TRH test: normal range and comparison with intravenous TRH test (author's transl)]. Passath A; Leb G; Goebel R Acta Med Austriaca; 1980; 7(3):80-7. PubMed ID: 6784435 [TBL] [Abstract][Full Text] [Related]
16. [TRH test II. Stimulation with thyrotropin releasing hormone(TRH) in patients with thyroid diseases]. Dige-Petersen H; Hummer L Ugeskr Laeger; 1974 Jun; 136(25):1356-60. PubMed ID: 4210164 [No Abstract] [Full Text] [Related]
17. Oral administration of the thyrotropin-releasing hormone (TRH) analogue, taltireline hydrate, in spinal muscular atrophy. Kato Z; Okuda M; Okumura Y; Arai T; Teramoto T; Nishimura M; Kaneko H; Kondo N J Child Neurol; 2009 Aug; 24(8):1010-2. PubMed ID: 19666885 [TBL] [Abstract][Full Text] [Related]
18. Time-dependent effects of oral thyrotropin-releasing hormone in hyperthyroid female rats. Iglesias R; Llobera M; Montoya E Horm Metab Res; 1986 Jul; 18(7):454-6. PubMed ID: 3091472 [TBL] [Abstract][Full Text] [Related]
19. [Triiodothyronine and thyroxine in the blood of patients with thyroid diseases after oral administration of thyrotropin releasing hormone (TRH)]. Nedvídková J; Felt V Vnitr Lek; 1976 May; 22(5):457-60. PubMed ID: 820069 [No Abstract] [Full Text] [Related]
20. Simultaneous use of thyrotropin-releasing hormone test and combined dexamethasone/corticotropine-releasing hormone test for severity evaluation and outcome prediction in patients with major depressive disorder. Isogawa K; Nagayama H; Tsutsumi T; Kiyota A; Akiyoshi J; Hieda K J Psychiatr Res; 2005 Sep; 39(5):467-73. PubMed ID: 15992555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]